DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
DBV Technologies S.A.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 16, 2026
$8.97−0.08 (-0.88%)
Close on Oct 19, 2026
- Market cap
- $3.89B
- P/E (TTM)
- –
- Dividend yield
- –
DBV Technologies statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Market Cap | $531.13M | $166.30M |
| Enterprise Value | $356.23M | $88.19M |
| PS Ratio | 105.83 | 3.65 |
| PB Ratio | 3.31 | 2.03 |
| P/TBV Ratio | 3.31 | 2.29 |
Enterprise value
| Measure | DBV Technologies | Industry median |
|---|---|---|
| EV / Sales | 70.98 | 2.51 |
Income (trailing twelve months)
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Revenue | $5.02M | $58.34M |
| Operating Income | -$177.83M | -$21.40M |
| Pretax Income | -$175.22M | -$14.34M |
| Net Income | -$175.99M | -$22.46M |
| EBITDA | -$177.83M | -$16.91M |
| EPS (Diluted) | -$0.71 | -$0.83 |
Margins
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Operating Margin | -3543.1% | -44.0% |
| Pretax Margin | -3491.1% | -13.3% |
| Profit Margin | -3506.5% | -40.2% |
| EBITDA Margin | -3543.1% | -30.2% |
| FCF Margin | -3399.3% | -9.27% |
Returns
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Return on Equity (ROE) | -142.7% | -53.2% |
| Return on Assets (ROA) | -96.0% | -40.9% |
| Return on Capital Employed (ROCE) | -105.3% | -38.1% |
Growth
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 29.3% | 5.96% |
| Revenue Growth (3Y CAGR) | 5.18% | 2.25% |
| Revenue Growth (5Y CAGR) | -13.0% | 6.48% |
Balance sheet
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $174.90M | $61.43M |
| Net Cash (Debt) | $174.90M | $15.35M |
| Net Cash Per Share | $0.59 | $0.66 |
| Equity (Book Value) | $160.40M | $49.09M |
| Book Value Per Share | $0.54 | $1.37 |
| Tangible Book Value | $160.40M | $23.52M |
| Working Capital | $147.60M | $76.81M |
Financial position
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Current Ratio | 3.72 | 3.34 |
| Quick Ratio | 3.22 | 2.44 |
Cash flow (trailing twelve months)
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Operating Cash Flow | -$169.28M | -$12.35M |
| Capital Expenditures | -$1.33M | -$1.08M |
| Free Cash Flow | -$170.61M | -$20.22M |
| FCF Per Share | -$0.58 | -$0.42 |
Efficiency
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Asset Turnover | 0.03 | 0.39 |
| Revenue Per Employee | $40.15K | $404.87K |
| Profits Per Employee | -$1.41M | -$703.34K |
| Employee Count | 125 | 74 |
Dividends and yields
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Earnings Yield | -33.1% | -23.3% |
| FCF Yield | -32.1% | -8.72% |
Shares
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Shares Outstanding | 296,061,000 | 58,127,000 |
| Shares Change (YoY) | 173.3% | 10.9% |
| Float | 258,090,000 | 49,136,700 |
| Shares Held by Insiders | 12.8% | 11.6% |
| Shares Held by Institutions | 7.27% | 59.4% |
Taxes
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Income Tax | $774.00K | $79.87K |
Scores
| Measure | DBV Technologies | Industry median |
|---|---|---|
| Altman Z-Score | 1.57 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from DBV Technologies's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.